Filter by
 

Origin

Publication date

Category

Main subject

Main subject

Keywords

Keywords

Geographical scope

Document language

EMCDDA Document Library

Displaying 31 - 40 of 85

HCV policies landscape in Europe, 2018 – EMCDDA commissioned study (contract CT.16.IBS.0156.1.0)

September 2018

In the context of its contribution to monitoring HCV elimination among PWID in Europe, the EMCDDA conducted a study on current HCV policies, assessing if and how these refer to people who inject drugs (PWID). This document contains a compilation of information about the current HCV policies in all...

Active case finding for communicable diseases in prison settings: increasing testing coverage and uptake among the prison population in the European Union/European Economic Area

June 2018

HCV promotional material example: Hepatitis C – det du har brug for at vide

November 2017

The leaflet covers basic information about hepatitis C, including its symptoms and the information about the new treatment available, without side effects. At the end it advises, that if you have shared syringes, water, filter, etc., then it is a good idea to get tested.

Drug checking as a harm reduction tool for recreational drug users: opportunities and challenges

October 2017

A number of European countries have implemented drug checking with the aim of providing targeted preventive messages to recreational drug users. This approach, which is more individualised than mass media campaigns, provides an incentive for drug users to participate in a dialogue about prevention...

Responding to the needs of ageing drug users

October 2017

Older people with drug problems (OPDP) are considered those aged 40 or over whose recurrent drug use is causing them harm or is placing them at a high risk of such harm OPDP are likely to encounter negative life outcomes due to their drug use and they have characteristics and trajectories distinct...

User-led interventions: an expanding resource?

October 2017

This short paper outlines the growth of user-led interventions across Europe in the problem (as opposed to recreational) drug sector over recent years. It starts by attempting to define and categorise user-led interventions before describing a number of examples and sharing what is known about...

Recovery, reintegration, abstinence, harm reduction: the role of different goals within drug treatment in the European context

October 2017

The purpose of this paper is to discuss the different goals of ‘drug treatment’ within a European context and the key implications for those planning or delivering health and social responses. The heterogeneity of people who use drugs and the diversity in severity and complexity of drug taking and...

Joining up sexual health and drug services to better meet client needs

October 2017

The aim of this paper is to focus on the harmful interaction between psychoactive drug use and sexual activity. It is acknowledged that in some individuals co-occurrence of drug consumption and sexual activity causes no apparent harm, but this group will not be considered here.

Criminal justice and drug policy: treatment, harm reduction and alternatives to punishment

September 2017

Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus study

April 2017

Despite advances in our knowledge of effective services for people who use drugs over the last decades globally, coverage remains poor in most countries, while quality is often unknown. This paper aims to discuss the historical development of successful epidemiological indicators and to present a...

Loading